Pathward Financial, Inc. (CASH)
(Delayed Data from NSDQ)
$51.09 USD
+0.34 (0.67%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $51.06 -0.03 (-0.06%) 7:54 PM ET
3-Hold of 5 3
A Value D Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$51.09 USD
+0.34 (0.67%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $51.06 -0.03 (-0.06%) 7:54 PM ET
3-Hold of 5 3
A Value D Growth C Momentum C VGM
Zacks News
Pathward (CASH) Launches a Line of Credit for Underserved
by Zacks Equity Research
Pathward (CASH) launches the Pathward Line of Credit in partnership with Propel to provide credit solutions to the underserved population.
Invesco (IVZ) Aided by Robust AUM Amid a Fall in Revenues
by Zacks Equity Research
Lower expenses, robust AUM balance, diverse product offerings and global presence are likely to keep supporting Invesco (IVZ). Yet, a challenging operating environment will hamper top-line growth.
Morgan Stanley's (MS) Inorganic Expansion Aids Amid High Costs
by Zacks Equity Research
Strategic business expansion efforts to focus on WM & IM segments are likely to support Morgan Stanley (MS). Yet, rising expenses and uncertain performance of capital markets are headwinds.
Associated Banc-Corp (ASB) Rides on Organic Growth Amid Cost Woes
by Zacks Equity Research
Strategic business expansion initiatives, decent loan demand and higher rates will continue to aid Associated Banc-Corp's (ASB) financials amid huge commercial loan exposure and mounting expenses.
Moody's (MCO) Aided by Strategic Buyouts Amid Rising Costs
by Zacks Equity Research
Focus on diversifying revenues and inorganic expansion initiatives are likely to support Moody's (MCO) amid stiff competition and mounting operating expenses.
Cullen/Frost (CFR) Aided by High Interest Rates Amid Cost Woes
by Zacks Equity Research
Cullen/Frost (CFR) continues to benefit from higher loans, rising interests and franchise expansion moves. However, deteriorating credit quality and an undiversified loan portfolio are concerning.
Fifth Third (FITB) Rides on Organic Growth Amid Cost Woes
by Zacks Equity Research
Diversified revenue sources, along with a rise in loans and deposits, are likely to support Fifth Third (FITB). However, mounting expenses and major exposure to commercial loans are headwinds.
5 Reasons Why Trustmark Corporation (TRMK) Stock Is a Must Buy
by Zacks Equity Research
A solid loan and deposit balance, higher rates and a focus on improving fee income are likely to continue to support Trustmark Corporation's (TRMK) financials going forward.
Northern Trust (NTRS) Rolls Out A-Suite for Asset Owners
by Zacks Equity Research
Northern Trust's (NTRS) A-Suite will offer content, research and peer networking opportunities to asset owners and allocators.
Citigroup's (C) Streamlining Effort Aids Amid Cost Woes
by Zacks Equity Research
Citigroup's (C) efforts to divest its consumer banking business internationally and diversifying revenue sources are likely to support financials. However, high costs and legal hassles are concerning.
BOK Financial (BOKF) Forays Into San Antonio for Texas Expansion
by Zacks Equity Research
BOK Financial's (BOKF) debut in San Antonio underlines its efforts to expand in the Texas region. The company will benefit from the dynamic and fast-growing market.
T. Rowe Price's (TROW) Revenues & AUM Aid Amid Rising Expenses
by Zacks Equity Research
Rising revenues backed by AUM growth and inorganic expansion moves are likely to support T. Rowe Price (TROW). Yet, elevated expenses and overdependence on investment advisory fees are concerns.
Synovus' (SNV) Balance Sheet Profile Aids Amid High Costs
by Zacks Equity Research
Strong balance sheet growth and a rise in revenues are likely to keep supporting Synovus (SNV). However, a rise in expenses and a concentrated loan portfolio are the major headwinds.
Revenue Growth Aids Northern Trust (NTRS) Amid High Costs
by Zacks Equity Research
Rising non-interest income, NII and growth in loan balances are likely to aid Northern Trust's (NTRS) revenues. However, high costs, volatile markets and deteriorating credit quality are concerning.
UBS Group (UBS) to Keep 100 Credit Suisse IB Jobs in Asia
by Zacks Equity Research
UBS Group (UBD) plans to fortify its talent pool across Asia to better compete with its rival with a stronger presence by retaining more than 100 investment bankers of Credit Suisse post the merger.
Revenue Growth Supports Sallie Mae (SLM) Amid High Costs
by Zacks Equity Research
Strategic buyouts, rising NII and loan growth to aid Sallie Mae's (SLM) revenues in the upcoming period. However, overdependence on brokered deposits as a funding source and high costs are concerns.
Schwab (SCHW) Rides on Buyouts, Higher Rates Amid Rising Costs
by Zacks Equity Research
Schwab (SCHW) continues to benefit from an increasing client base, higher interest rates and inorganic growth efforts. However, rising expenses and decreasing trading revenues are concerns.
Are Finance Stocks Lagging KE Hodlings (BEKE) This Year?
by Zacks Equity Research
Here is how KE Holdings Inc. Sponsored ADR (BEKE) and Pathward Financial (CASH) have performed compared to their sector so far this year.
Revenue Growth Supports U.S. Bancorp (USB) Amid High Cost
by Zacks Equity Research
U.S. Bancorp's (USB) organic growth is aided by solid loan and deposit balances. Also, rising NII and inorganic growth moves support revenues. Yet, high costs and loan concentration are headwinds.
Wells Fargo (WFC) Rides on Deposit Growth Amid Lower Revenues
by Zacks Equity Research
Strong deposit growth and cost-saving initiatives are likely to keep supporting Wells Fargo (WFC). However, a decline in revenues and a fall in loan balance are major headwinds.
Raymond James (RJF) Aided by Strategic Buyouts Amid IB Woes
by Zacks Equity Research
A strong balance sheet, opportunistic buyouts and PCG segment performance are likely to keep supporting Raymond James (RJF). However, elevated expenses and the volatile nature of the IB business are headwinds.
F.N.B. Corp (FNB) Rides on Loans & Buyouts Amid Cost Woes
by Zacks Equity Research
Decent loan demand, higher rates, focus on improving fee income and strategic acquisitions are expected to keep supporting F.N.B. Corp (FNB) amid rising expenses and a worsening economic outlook.
UMB Financial (UMBF) Hurt by Rising Costs and Competition
by Zacks Equity Research
An increase in non-interest expenses and growing competition are major headwinds for UMB Financial (UMBF). Nonetheless, solid loan and deposit balances, and decent liquidity offer some support.
Loan Growth Supports M&T Bank (MTB) Despite Rising Costs
by Zacks Equity Research
M&T Bank's (MTB) top line gets support from increasing loan and deposit balances. Continued rising expenses keep the bottom line under pressure, while worsening credit quality is worrisome.
Webster Financial (WBS) Hurt by High Debt Despite Loan Growth
by Zacks Equity Research
Webster Financial's (WBS) high debt levels, unsustainable capital-deployment activities and loan portfolio concentration make it an unsafe bet. Yet, high rates and robust loan growth are tailwinds.